Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety

International Journal of Nanomedicine

(2020) · International Journal of Nanomedicine · doi:10.2147/ijn · Cited by 2,760 · see citing works

Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse

Irwin, S. (1968) · Psychopharmacology · doi:10.1007/bf00401402 · Cited by 1,240 · see citing works

Iranian Journal of Pharmaceutical Research

(2022) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr · Cited by 1,229 · see citing works

Blood–brain barrier delivery

Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191 · see citing works

Chitosan Nanoparticles: A Promising System in Novel Drug Delivery

Nagpal, K., Singh, S. K., & Mishra, D. N. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.1423 · Cited by 661 · see citing works

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438 · see citing works

New Acetylcholinesterase Inhibitors for Alzheimer's Disease

Mehta, M., Adem, A., & Sabbagh, M. N. (2011) · International Journal of Alzheimer s Disease · doi:10.1155/2012/728983 · Cited by 436 · see citing works

Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting

Fazil, M., Md, S., Haque, S., Kumar, M., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.04.013 · Cited by 379 · see citing works

The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System

Nerurkar, M. M., Burton, P. S., & Borchardt, R. T. (1996) · Pharmaceutical Research · doi:10.1023/a:1016033702220 · Cited by 287 · see citing works

Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model

Wagner, S., Zensi, A., Wien, S., Tschickardt, S., Maier, W., Vogel, T., Worek, F., Pietrzik, C. U., Kreuter, J., & von Briesen, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032568 · Cited by 260 · see citing works

Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies

Joshi, S. A., Chavhan, S. S., & Sawant, K. K. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.07.007 · Cited by 235 · see citing works

Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles

Lin, X., Tian, Wei, Feng, Huang, Wang, Ren, R., & Diao (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16570 · Cited by 189 · see citing works

Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer’s disease

Fodale, V., Santamaria, L. B., Schifilliti, D., & Mandal, P. K. (2010) · Anaesthesia · doi:10.1111/j.1365-2044.2010.06244.x · Cited by 169 · see citing works

Chitosan‐Based Systems for Biopharmaceuticals

(2012) · Wiley eBooks · doi:10.1002/9781119962977 · Cited by 134 · see citing works

Cardiac Toxicity of Antineoplastic Anthracyclines

Zucchi, R., & Danesi, R. (2003) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011033353434 · Cited by 129 · see citing works

Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB

Nagpal, K., Singh, S. K., & Mishra, D. N. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.762354 · Cited by 115 · see citing works

Risk assessment for glucosamine and chondroitin sulfate

Hathcock, J. N., & Shao, A. E. (2006) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2006.07.004 · Cited by 106 · see citing works

Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier

Wohlfart, S., Khalansky, A. S., Gelperina, S. E., Begley, D. J., & Kreuter, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.010 · Cited by 100 · see citing works

Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity

Lee, Y. K., Yuk, D. Y., Kim, T. I., Kim, Y. H., Kim, K., Kim, K. H., Lee, B. J., Nam, S.-Y., & Hong, J. T. (2009) · Journal of Natural Medicines · doi:10.1007/s11418-009-0330-z · Cited by 97 · see citing works

Delivery of nanoparticles to the brain detected by fluorescence microscopy

Reimold, I., Domke, D., Bender, J., Seyfried, C. A., Radunz, H.-E., & Fricker, G. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.007 · Cited by 89 · see citing works

Asparagus recemosus enhances memory and protects against amnesia in rodent models

Ojha, R., Sahu, A. N., Muruganandam, A. V., Singh, G. K., & Krishnamurthy, S. (2010) · Brain and Cognition · doi:10.1016/j.bandc.2010.05.009 · Cited by 84 · see citing works

Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: Focus on cardio- and testicular toxicity

Переверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Langer, K., Dreis, S., Asmussen, B., Kreuter, J., & Gelperina, S. E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.031 · Cited by 76 · see citing works

Design and Evaluation of Chitosan Nanoparticles As Novel Drug Carrier for the Delivery of Rivastigmine to Treat Alzheimer‘s Disease

Wilson, B., Samanta, M. K., Muthu, M. S., & Vinothapooshan, G. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.21 · Cited by 74 · see citing works

Current Medicinal Chemistry - Anti-Cancer Agents

(2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/cmcaca-15680118-662 · Cited by 71 · see citing works

In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain

Wei, F., Tian, T., Wei, F., Wang, T., Wang, P., Lin, X., Wang, J., Wang, D., & Ren, L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26541 · Cited by 67 · see citing works

Nanoparticle mediated brain targeted delivery of gallic acid:in vivobehavioral and biochemical studies for improved antioxidant and antidepressant-like activity

Nagpal, K., Singh, S. K., & Mishra, D. N. (2012) · Drug Delivery · doi:10.3109/10717544.2012.738437 · Cited by 64 · see citing works

Biochemical Differentiation of Cholinesterases from Normal and Alzheimers Disease Cortex

Ciro, A., Park, J., Burkhard, G., Yan, N., & Geula, C. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015127 · Cited by 58 · see citing works

Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells

Ricci‐Júnior, E., dos Santos, E. P., de Brito‐Gitirana, L., Volta, Oliveira, Moreno, & Holandino, C. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s15860 · Cited by 52 · see citing works

Formulation, Optimization, in Vivo Pharmacokinetic, Behavioral and Biochemical Estimations of Minocycline Loaded Chitosan Nanoparticles for Enhanced Brain Uptake

Nagpal, K., Singh, S. K., & Mishra, D. N. (2013) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c12-00732 · Cited by 41 · see citing works

The formulation, characterization andin vivoevaluation of a magnetic carrier for brain delivery of NIR dye

Raut, S., Kirthivasan, B., Bommana, M. M., Squillante, E., & Sadoqi, M. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/39/395102 · Cited by 35 · see citing works

Optimization of brain targeted gallic acid nanoparticles for improved antianxiety-like activity

Nagpal, K., Singh, S. K., & Mishra, D. N. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.03.022 · Cited by 30 · see citing works

High-performance liquid chromatographic determination of rivastigmine in human plasma for application in pharmacokinetic studies.

Amini, H., & Ahmadiani, A. (2010) · Europe PMC (PubMed Central) · Cited by 18 · see citing works

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works

Chitosan in nasal delivery systems for therapeutic drugs

Casettari, L., & Illum, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.003 · Cited by 448 · see citing works

Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity

Elnaggar, Y. S. R., Etman, S. M., Abdelmonsif, D. A., & Abdallah, O. Y. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24557 · Cited by 327 · see citing works

The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives

Jurcău, M. C., Andronie-Cioara, F. L., Jurcău, A., Marcu, F., Ţiț, D. M., Pașcalău, N., & Nistor-Cseppentö, D. C. (2022) · Antioxidants · doi:10.3390/antiox11112167 · Cited by 226 · see citing works

Interests of chitosan nanoparticles ionically cross-linked with tripolyphosphate for biomedical applications

Bugnicourt, L., & Ladavière, C. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.06.002 · Cited by 202 · see citing works

Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System

Ojeda-Hernández, D. D., Canales-Aguirre, A. A., Matías‐Guiu, J., Gómez‐Pinedo, U., & Mateos‐Díaz, J. C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00389 · Cited by 172 · see citing works

Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters

Cunha, S., Costa, C. P., Loureiro, J. A., Alves, J., Peixoto, A. F. R. O., Forbes, B., Lobo, J. M. S., & Silva, A. C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070599 · Cited by 156 · see citing works

Ursolic acid liposomes with chitosan modification: Promising antitumor drug delivery and efficacy

Wang, M., Zhao, T., Liu, Y., Wang, Q., Xing, S., Li, L., Wang, L., Liu, L., & Gao, D. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.11.014 · Cited by 136 · see citing works

Resveratrol anchored nanostructured lipid carrier loaded in situ gel via nasal route: Formulation, optimization and in vivo characterization

Rajput, A., & Butani, S. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.01.040 · Cited by 114 · see citing works

Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers

Caprifico, A. E., Foot, P. J. S., Polycarpou, E., & Calabrese, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111013 · Cited by 108 · see citing works

Chitosan-Based Nanocarriers for Nose to Brain Delivery

Aderibigbe, B. A., & Naki, T. (2019) · Applied Sciences · doi:10.3390/app9112219 · Cited by 104 · see citing works

Nanoparticle technology for treatment of Parkinson’s disease: The role of surface phenomena in reaching the brain

Leyva-Gómez, G., Cortés, H., Magaña, J. J., Leyva-García, N., Quintanar-Guerrero, D., & Florán, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.009 · Cited by 102 · see citing works

PREPARATION OF CHITOSAN-TPP NANOPARTICLES: THE INFLUENCE OF CHITOSAN POLYMERIC PROPERTIES AND FORMULATION VARIABLES

Al‐Nemrawi, N. K., Alsharif, S. S. M., & Dave, R. H. (2018) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2018v10i5.26375 · Cited by 97 · see citing works

Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer’s Disease

Manek, E., Darvas, F., & Petroianu, G. A. (2020) · Molecules · doi:10.3390/molecules25204866 · Cited by 97 · see citing works

Optimize the parameters for the synthesis by the ionic gelation technique, purification, and freeze-drying of chitosan-sodium tripolyphosphate nanoparticles for biomedical purposes

Gutiérrez-Ruíz, S. C., Cortés, H., González‐Torres, M., Almarhoon, Z. M., Gürer, E. S., Sharifi‐Rad, J., & Leyva‐Gómez, G. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00403-w · Cited by 94 · see citing works

Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform

Pinto, M., Silva, V., Barreiro, S., Silva, R. V. D. S., Remião, F., Borges, F., & Fernandes, C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101658 · Cited by 94 · see citing works

Novel polydatin-loaded chitosan nanoparticles for safe and efficient type 2 diabetes therapy: In silico, in vitro and in vivo approaches

Abdel‐Moneim, A., El‐Shahawy, A. A. G., Yousef, A. I., El-Twab, S. M. A., Elden, Z. E., & Taha, M. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.031 · Cited by 86 · see citing works

Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate

Simon, A., Amaro, M. I., Cabral, L. M., Healy, A. M., & de Sousa, V. P. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.066 · Cited by 84 · see citing works

In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization

Rajput, A., Bariya, A. H., Allam, A. A., Othman, S. I., & Butani, S. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0540-6 · Cited by 83 · see citing works

Green synthesis of hydrolyzed starch–chitosan nano-composite as drug delivery system to gram negative bacteria

Shehabeldine, A. M., & Hasanin, M. S. (2019) · Environmental Nanotechnology Monitoring & Management · doi:10.1016/j.enmm.2019.100252 · Cited by 76 · see citing works

Optimization of rivastigmine nanoemulsion for enhanced brain delivery: In-vivo and toxicity evaluation

Haider, M. F., Khan, S., Gaba, B., Alam, T., Baboota, S., Ali, J., & Ali, A. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.01.123 · Cited by 68 · see citing works

Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease

Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.024 · Cited by 65 · see citing works

The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders

Ngowi, E. E., Wang, Y., Qian, L., Helmy, Y. A. S. H., Anyomi, B. K., Li, T., Zheng, M., Jiang, E., Duan, S., Wei, J., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.629832 · Cited by 68 · see citing works

Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study

Kaur, H., Ghosh, S., Kumar, P., Basu, B., & Nagpal, K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119927 · Cited by 59 · see citing works

Advances in Nanomedicine for the Treatment of Alzheimer’s and Parkinson’s Diseases

Hernando, S., Gartziandia, O., Herrán, E., Pedraz, J. L., Igartúa, M., & Hernández, R. M. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0019 · Cited by 48 · see citing works

Quality-by-design driven analytical method (AQbD) development and validation of HPLC–UV technique to quantify rivastigmine hydrogen tartrate in lipidic nanocarriers: Forced degradation, and assessment of drug content and in vitro release studies

Salwa, & Kumar, L. (2023) · Microchemical Journal · doi:10.1016/j.microc.2023.108944 · Cited by 47 · see citing works

Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go

Prasanna, P., & Upadhyay, A. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00224 · Cited by 46 · see citing works

Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects

Chopra, H., Bibi, S., Singh, I., Kamal, M. A., Islam, F., Alhumaydhi, F. A., Emran, T. B., & Cavalu, S. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879114 · Cited by 47 · see citing works

A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises

Khodaverdi, K., Bakhshi, A., Mozafari, M. R., & Naghib, S. M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134962 · Cited by 45 · see citing works

Polydatin-loaded chitosan nanoparticles ameliorates early diabetic nephropathy by attenuating oxidative stress and inflammatory responses in streptozotocin-induced diabetic rat

El-Hameed, A. M. A. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00699-7 · Cited by 43 · see citing works

Synthesis, characterization and evaluation of antioxidant properties of catechin hydrate nanoparticles

Kaur, R., Rajput, R., Nag, P., Kumar, S., Rachana, R., & Singh, M. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.04.030 · Cited by 40 · see citing works

Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia

Liu, S., & Ho, P. C. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12797 · Cited by 39 · see citing works

The Effect of Cannabidiol Coated by Nano-Chitosan on Learning and Memory, Hippocampal CB1 and CB2 Levels, and Amyloid Plaques in an Alzheimer’s Disease Rat Model

Amini, M., & Abdolmaleki, Z. (2021) · Neuropsychobiology · doi:10.1159/000519534 · Cited by 36 · see citing works

Natural biomaterials in brain repair: A focus on collagen

Uçar, B. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105033 · Cited by 34 · see citing works

Characterization of alginate/chitosan-based nanoparticles and mathematical modeling of their SpBMP-9 release inducing neuronal differentiation of human SH-SY5Y cells

Lauzon, M.-A., Marcos, B., & Faucheux, N. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.11.075 · Cited by 31 · see citing works

Significance of Algal Polymer in Designing Amphotericin B Nanoparticles

Bhatia, S., Kumar, V., Sharma, K., Nagpal, K., & Bera, T. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/564573 · Cited by 27 · see citing works

Synthesis of a Rivastigmine and Insulin Combinational Mucoadhesive Nanoparticle for Intranasal Delivery

Jamshidnejad-Tosaramandani, T., Kashanian, S., Karimi, I., & Schiöth, H. B. (2024) · Polymers · doi:10.3390/polym16040510 · Cited by 28 · see citing works

Hepatoprotective Effects of Polydatin-Loaded Chitosan Nanoparticles in Diabetic Rats: Modulation of Glucose Metabolism, Oxidative Stress, and Inflammation Biomarkers

El-Hameed, A. M. A., Yousef, A. I., El-Twab, S. M. A., El‐Shahawy, A. A. G., & Abdel‐Moneim, A. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921020061 · Cited by 26 · see citing works

Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders

Grosso, C., Silva, A., Delerue-Matos, C. M., & Barroso, M. F. (2023) · Pharmaceuticals · doi:10.3390/ph16121721 · Cited by 24 · see citing works

Preparation and characterization of kanamycin-chitosan nanoparticles to improve the efficacy of antibacterial activity against nosocomial pathogens

Kumar, G. V., Su, C., & Velusamy, P. (2016) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2016.05.054 · Cited by 23 · see citing works

Neuroprotective effect of piracetam-loaded magnetic chitosan nanoparticles against thiacloprid-induced neurotoxicity in albino rats

Abomosallam, M., Hendam, B. M., Abdallah, A. A., Refaat, R., Elshatory, A., & El-Hak, H. N. G. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01151-x · Cited by 22 · see citing works

Formulation and characterization of chitosan nanoparticles loaded with neuroprotective flavonoid from Phyllanthus niruri Linn

Rajamanickam, G., & Manju, S. L. (2023) · Macromolecular Research · doi:10.1007/s13233-023-00114-z · Cited by 22 · see citing works

Carbohydrate Nanoparticles for Brain Delivery

Lalatsa, A., & Barbu, E. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.05.004 · Cited by 22 · see citing works

Drug Delivery Systems and Strategies to Overcome the Barriers of Brain

Garg, Y., Kapoor, D. N., Sharma, A. K., & Bhatia, A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612828666211222163025 · Cited by 20 · see citing works

Polyphenols and Their Biogenic Nano‐Formulations Targeting BACE1 as Anti‐Amyloid Therapies; Meeting the Challenges of Bioavailability, Safety, and Specificity for the Treatment of Alzheimer's Disease

Elawad, M. A., Ayaz, M., Mosa, O. F., Usman, A., Hamdoon, A. A. E., Almawash, S., Salim, L. H. M., Ahmed, A., & Elkhalifa, M. E. M. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400525 · Cited by 20 · see citing works

Characterization and Mathematical Modeling of Alginate/Chitosan-Based Nanoparticles Releasing the Chemokine CXCL12 to Attract Glioblastoma Cells

Gascon, S., Solano, A. G., Kheir, W. E., Therriault, H., Berthelin, P., Cattier, B., Marcos, B., Virgilio, N., Paquette, B., Faucheux, N., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040356 · Cited by 20 · see citing works

Nanomedicine against Alzheimer’s and Parkinson’s Disease

Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 19 · see citing works

Chitosan based nanocarriers as a promising tool in treatment and management of inflammatory diseases

Goyal, S., Thirumal, D., Rana, J., Gupta, A. K., Kumar, A., Babu, M. A., Kumar, P., & Sindhu, R. K. (2024) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2024.100442 · Cited by 19 · see citing works

Dual-Targeting Liposomes for Enhanced Anticancer Effect in Somatostatin Receptor II-Positive Tumor Model

Li, L., Wang, Q., Zhang, X., Luo, L., He, Y., Zhu, R., & Gao, D. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0115 · Cited by 18 · see citing works

Alternative methods for the pilot-scale production and characterization of chitosan nanoparticles

Alves, H. J., Gasparrini, L. J., Silva, F. E. B., Caciano, L., de Muñiz, G. I. B., Ballester, E. L. C., Cremonez, P. A., & Arantes, M. K. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-11343-5 · Cited by 17 · see citing works

Rivastigmine hydrogen tartrate polymorphs: Solid-state characterisation of transition and polymorphic conversion via milling

Amaro, M. I., Simon, A., Cabral, L. M., de Sousa, V. P., & Healy, A. M. (2015) · Solid State Sciences · doi:10.1016/j.solidstatesciences.2015.09.004 · Cited by 17 · see citing works

Treatment of Alzheimer's Disease: Classical Therapeutic Approach

Bajić, V., Sudar-Milovanovic, E. M., Spremo‐Potparević, B., Živković, L., Milicevic, Z., Stanimirović, J., Bogdanović, N., & Isenović, E. R. (2015) · Current Pharmaceutical Analysis · doi:10.2174/1573412911666150611184740 · Cited by 16 · see citing works

Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases

Wang, Z., Gonzalez, K. M., Cordova, L. E., & Lu, J. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1907 · Cited by 18 · see citing works

Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy

Liu, C., Wu, K.-Z., Gao, H. X., Li, J., & Xu, X. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s380550 · Cited by 15 · see citing works

An applied quantum-chemical model for genipin-crosslinked chitosan (GCS) nanocarrier

Nasrabadi, M., Morsali, A., & Beyramabadi, S. A. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.10.013 · Cited by 15 · see citing works

Toxicological study of the Primaquine phosphate loaded chitosan nanoparticles in mice

Rajera, R., Nagpal, K., Singh, S. K., & Mishra, D. N. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.08.019 · Cited by 15 · see citing works

Chitosan Nanoparticles Alleviated the Adverse Effects of Sildenafil on the Oxidative Stress Markers and Antioxidant Enzyme Activities in Rats

Sheweita, S. A., Alian, D. M. E., Haroun, M., Nounou, M. I., Patel, A. A., & El-Khordagui, L. K. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/9944985 · Cited by 14 · see citing works

Alzheimer hastalığı tedavisinde nano boyutlu ilaç taşıyıcı sistemlerin kullanımı

GÜN, D. N. (2016) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.1501/eczfak_0000000579 · Cited by 13 · see citing works

The current advancements in chitosan nanoparticles in the management of non-surgical periodontitis treatment

Shamami, M. S., Ekhlaspour, M., Sulaiman, J. M. A., Kareem, R. A., Alsultany, N. M. A., Nasiri, K., & Shenasa, N. (2025) · Nanotoxicology · doi:10.1080/17435390.2025.2484002 · Cited by 11 · see citing works

Revolutionizing Neurological Therapies: The Multifaceted Potential of Zein-Based Nanoparticles for Brain-Targeted Drug Delivery

Narayan, S., Gupta, P. K., & Nagpal, K. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00062 · Cited by 12 · see citing works

Intranasal delivery of chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: A comprehensive review of advanced strategies for CNS targeting

Ibrahim, R. M., Teaima, M. H. M., El-Nabarawi, M. A., & Badawi, N. M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105885 · Cited by 10 · see citing works

Polyphenol-conjugated polysaccharide nanoplatforms for enhanced therapeutic efficacy

Narayan, S., Nagpal, K., & Kumar, P. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2514714 · Cited by 10 · see citing works

In situ encapsulation of rivastigmine in TAT-functionalized P(MMA-co-AA) nanoparticles through miniemulsion polymerization

Mangia, L. H. R., Ferraz, H. C., de Souza, R. S., Pereira, M. C. D. S., & Pinto, J. C. (2021) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2021.126776 · Cited by 10 · see citing works

Formulation and Characterization of Propranolol Nanoparticles for Transmucosal Nasal Drug Delivery

Nag, P., Rajput, R., Dhaliwal, S., Kumar, S., Prajapat, D., & Singh, M. (2015) · Macromolecular Symposia · doi:10.1002/masy.201400051 · Cited by 9 · see citing works

Design and Development of Lomustine Loaded Chitosan Nanoparticles for Efficient Brain Targeting

Anand, A., Iyer, B. R., Ponnusamy, C., Pandiyan, R., & Sugumaran, A. (2020) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525718666200203112502 · Cited by 9 · see citing works

A Stability Indicating HPLC Assay Method for Analysis of Rivastigmine Hydrogen Tartrate in Dual-Ligand Nanoparticle Formulation Matrices and Cell Transport Medium

Huda, N. H., Gauri, B., Benson, H. A., & Chen, Y. (2018) · Journal of Analytical Methods in Chemistry · doi:10.1155/2018/1841937 · Cited by 9 · see citing works

Minocycline encapsulated chitosan nanoparticles for central antinociceptive activity

Nagpal, K., Singh, S. K., & Mishra, D. N. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.07.055 · Cited by 8 · see citing works

Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease

Choubdar, N., & Avizheh, S. (2019) · Nanoscience &amp Nanotechnology-Asia · doi:10.2174/2210681209666190228143636 · Cited by 7 · see citing works

Intranasal administration of in silico designed Rivastigmine mucoadhesive nanoparticles ameliorates scopolamine-induced Alzheimer’s symptoms in mice: Pharmacokinetic and pharmacodynamic evidences

Kalra, V., Silakari, O., & Tiwary, A. K. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125635 · Cited by 6 · see citing works

Polydatin nanoparticles attenuate oxidative stress and histopathological changes in streptozotocin model of diabetic nephropathy: targeting Nrf2/HO-1/NF-κβ signaling pathways

Abdul‐Hamid, M., Galaly, S. R., Mohamed, H. M., Mostafa, F., & Abdel‐Moneim, A. (2023) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-023-00441-1 · Cited by 6 · see citing works

Biopolymers as promising vehicles for drug delivery to the brain

Mythri, R. B., & Aishwarya, M. (2023) · Drug Metabolism Reviews · doi:10.1080/03602532.2023.2281855 · Cited by 6 · see citing works

Advances in Neurotherapeutic Delivery Technologies

Mr Pradeep, K. (2015) · OMICS International eBooks · doi:10.4172/978-1-63278-036-2-037 · Cited by 6 · see citing works

Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review

Silva, S., Almeida, A. J., & Vale, N. (2021) · Journal of Nanoparticle Research · doi:10.1007/s11051-020-05118-9 · Cited by 6 · see citing works

Nanoparticle-mediated delivery of AChE inhibitors for the treatment of Alzheimer’s disease

Namdeo, P., Mathew, J., & Garg, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00004-6 · Cited by 5 · see citing works

Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients

Bhattacharya, S. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1385272827666221027103050 · Cited by 6 · see citing works

Rivastigmine

Ezzat, S. M., Salem, M. A., El Mahdy, N. M., & Ragab, M. F. (2021) · Naturally Occurring Chemicals Against Alzheimer's Disease · doi:10.1016/b978-0-12-819212-2.00007-4 · Cited by 4 · see citing works

Nanotechnology Based Approaches for Neurodegenerative Disorders: Diagnosis and Treatment

Hernando, S., Herrán, E., Pedraz, J. L., Igartúa, M., & Hernández, R. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-57696-1_3 · Cited by 4 · see citing works

Nanopolymer Chitosan in Cancer and Alzheimer Biomedical Application

Putri, A. D., Murti, B. T., Sabela, M. I., Kanchi, S., & Bisetty, K. (2017) · doi:10.1002/9781119364849.ch12 · Cited by 4 · see citing works

Tween 80-Modified Chitosan Nanoparticles via Ionotropic Gelation for Enhanced Brain Delivery of Chrysin and Improved Anxiolytic Efficacy in Preclinical Models

Dey, P., Narayan, S., & Nagpal, K. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00611 · Cited by 3 · see citing works

A Medico-Biological Approach to Chitosan Bionanocomposites

Khanna, N., Chatterji, T., Singh, S., & Khanna, N. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9646-7_3 · Cited by 3 · see citing works

Chitosan-based nanoparticles for the treatment of neurological disorders

Enejiyon, S. O., Komolafe, L. I., Ahmad, N. H., Muhammad, F. E., Okoye, U. M., Oyewole, O. A., & Adetunji, C. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13997-0.00014-x · Cited by 3 · see citing works

Polymeric nanoparticles as drug delivery systems for dementia

Esteruelas, G., Souto, E. B., Cano, A. C., Ettcheto, M., Espina, M., Camins, A., García, M. L., & Sánchez‐López, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824331-2.00006-6 · Cited by 3 · see citing works

Nanoengineering and nanotechnology for diagnosis and treatment of CNS and neurological diseases

Kumar, P., Dwivedi, A., Plaimas, K., Sagar, K., & Chauhan, L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91182-5.00006-1 · Cited by 3 · see citing works

Polymeric nanosystems for neurological therapeutics

Noah, N. M., & Ndangili, P. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85656-0.00010-3 · Cited by 3 · see citing works

Nano chitosan anchored copper-ferrite: a smart magnetic nanocomposite agent for drug delivery

Adebayo, A. O., Alli, Y. A., Bamisaye, A., & Adewuyi, S. (2023) · Emergent Materials · doi:10.1007/s42247-023-00584-y · Cited by 3 · see citing works

Development and characterization of nanostructured lipid carriers for sustained rivastigmine delivery in Alzheimer's disease

Assaf, S. M., Almnayyes, A. I., Obaidat, R., & Maaroof, K. T. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107803 · Cited by 2 · see citing works

Brain-targeted mucoadhesive in situ gel incorporating quercetin-PEG conjugate and rivastigmine-loaded chitosan nanoparticles for Alzheimer's therapy

Aslam, S., Tulain, U. R., Zahid, F., Ali, Z., Erum, A., Alamri, A. H., Fatease, A. M. A., Amin, M., Wan, G., & Din, F. U. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151998 · Cited by 2 · see citing works

Signaling Pathways Triggering Therapeutical Potential of Marine-Derived Polysaccharides in Alzheimer’s Disease: A Recent Review

Kumar, D., Kondaveeti, S. B., Agrawal, M., Kumar, A., Awasthi, A., Mahmood, S., Singh, T. G., & Kumar, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05857-1 · Cited by 2 · see citing works

Curcumin‐loaded nanoparticle based on poloxamer188 for glioma treatment: Synthesis, characterization and in vitro evaluation

Hou, X., Xu, J., He, S., Bai, J., Guan, Y., Pan, X., Yang, J., Zhang, N., Yang, S., Hu, J., et al. (2023) · Polymers for Advanced Technologies · doi:10.1002/pat.6120 · Cited by 2 · see citing works

Nose-to-Brain Drug Delivery Strategies for the Treatment of Neurological Disorders

Prabakaran, A., Bhatane, D., & Alexander, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_17 · Cited by 2 · see citing works

Thyme oil-loaded chitosan microparticles: an antibacterial approach against pathogenic bacteria

Thakur, A., & Sharma, K. (2025) · 3 Biotech · doi:10.1007/s13205-025-04301-w · Cited by 2 · see citing works

Tuning three-dimensional nano-assembly in the mesoscale via bis(imino)pyridine molecular functionalization

Brisbin, R., Bartolo, M., Leveille, M. P., Rajan, A. K., Jahan, B., McCloskey, K. E., Gopinathan, A., Ghosh, S., & Baxter, R. D. (2022) · Scientific Reports · doi:10.1038/s41598-022-04851-6 · Cited by 2 · see citing works

Fabrication and optimization of verapamil-loaded PEGylated nanoparticles for management of traumatic brain injury: a comparative evaluation

Amin, O. M., Khalifa, M. K. A., El-Fattah, M. A. A., Allam, A., Aboutaleb, A. S., & Al‐Najjar, A. H. (2025) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2025.2592102 · Cited by 1 · see citing works

Enhancement of the Anti-Inflammatory Effect of Zingerone Using the Galactosylated Chitosan Nano Formula Against CCl4-Induced Hepatic Fibrosis: An In Vivo Study

Ismail, S. M., Eldin, Z. E., Elbakkay, M. H., Abdel‐Moneim, A., El‐Shahawy, A. A. G., & Zanaty, M. I. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10595-x · Cited by 1 · see citing works

Nanoparticulate systems for sustained delivery of paracrine factors

Arabi, L., Ho, J. Q., Javdani, N., Jones, S. M., Chen, I., Sharaf, M., Aieneravaie, M., Georgala, P., Sepand, M. R., Rafat, M., et al. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817434-0.00011-8 · Cited by 1 · see citing works

Biological nanodrugs for brain targeting

Jovčevska, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00028-2 · Cited by 1 · see citing works

Neuroprotection through nanotechnology

Kaur, J., Khan, F. D., & Naqvi, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00080-4 · Cited by 1 · see citing works

Nanotechnological Drug Delivery Strategies in Epilepsy

Esteruelas, G., Bonilla-Vidal, L., Ettcheto, M., Haro, I., Gomara, M. J., Souto, E. B., Espina, M., Camins, A., García, M. L., Sánchez‐López, E., et al. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_14 · Cited by 1 · see citing works

De novo fabrication of oral insulin-loaded chitosan/dextrin/pectin nanospheres and their antidiabetic efficacy in streptozotocin-induced diabetic rats

Mohammed, S. R., Abdel‐Moneim, A., Abdel-Reheim, E., Ramadan, H., Eldin, Z. E., El‐Shahawy, A. A. G., & Yousef, A. I. (2024) · Journal of Optoelectronic and Biomedical Materials · doi:10.15251/jobm.2024.162.73 · Cited by 1 · see citing works

Biomarker detection of Parkinson’s disease: therapy and treatment using nanomaterials

Nanda, R., Panda, P., & Mishra, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817923-9.00017-1 · Cited by 1 · see citing works

Formulation development, systematic optimization of PLGA-CS-Tween 80nanoparticles of Rivastigmine Tartrate for treatment of Alzheimer’s disease

Patel, K. C., & Goli, D. (2015) · Der pharmacia lettre · Cited by 2 · see citing works

Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting

Fazil, M., Md, S., Haque, S., Kumar, M., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.04.013 · Cited by 379 · see citing works

Design and Evaluation of Chitosan Nanoparticles As Novel Drug Carrier for the Delivery of Rivastigmine to Treat Alzheimer‘s Disease

Wilson, B., Samanta, M. K., Muthu, M. S., & Vinothapooshan, G. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.21 · Cited by 74 · see citing works

OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS

El-Assal, M. I. A., & SAMUEL, D. (2022) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2022v14i1.43145 · Cited by 27 · see citing works

Simar preet Kaur et al /J. Pharm. Sci. & Res. Vol.3(5), 2011,1227-1232 Preparation and Characterization of Rivastigmine Loaded Chitosan

Kaur, S. P., Rao, R., Hussain, A., & Khatkar, S. (2012)